• News
    • Opinion Editorial
    • Videos
    • Podcasts
  • Community
    • Members
  • Discussions
  • Patient Centers
    • View All
    • Why Join?
  • Write for us
    Sign in Sign up


    • News
      • Opinion Editorial
      • Videos
      • Podcasts
    • Community
      • Members
    • Discussions
    • Patient Centers
      • View All
      • Why Join?
    • Write for us
    Sign in Sign up

    Tag: Variants

    NIAID-Led Study Indicates SARS-CoV-2 Specific CD8+T Cell Responses Generally Effective Against Variants But More Study Needed

    NIAID-Led Study Indicates SARS-CoV-2 Specific CD8+T Cell Responses Generally Effective Against Variants But More Study Needed

    The National Institute of Allergy and Infectious Diseases (NIAID) recently announced promising results from a small but important study involving 30 recovered COVID-19 patients infected…

    TrialSite Staff
    TrialSite Staff March 31, 2021
    0 Comments
    Washington University School of Medicine Study Reveals COVID-19 Vaccines & mAbs Less Effective Against South African & Brazilian Variants

    Washington University School of Medicine Study Reveals COVID-19 Vaccines & mAbs Less Effective Against South African & Brazilian Variants

    Recent research from the Washington University School of Medicine in St. Louis suggests that dangerous, new, fast spreading SARS-CoV-2 variants can avoid antibodies that work…

    TrialSite Staff
    TrialSite Staff March 6, 2021
    1 Comment
    Broad Institute & UBC Researchers Develop COVID-19 Tracking Tool to Help Identify Mutations by Geography

    Broad Institute & UBC Researchers Develop COVID-19 Tracking Tool to Help Identify Mutations by Geography

    A research team from the Broad institute, the University of British Columbia and 4Fusion Genomics Corporation have developed an open, free public browser resource for tracking COVID-19 virus…

    TrialSite Staff
    TrialSite Staff March 2, 2021
    0 Comments
    Moderna Announces Strategies & Updates Associated with Variant-Specific Vaccine while Forecasting $18.4b in Revenue

    Moderna Announces Strategies & Updates Associated with Variant-Specific Vaccine while Forecasting $18.4b in Revenue

    Moderna Inc. (Nasdaq: MRNA), the biotechnology company with one of the authorized vaccines for COVID-19, completed the manufacturing of clinical trial material for its variant-specific…

    TrialSite Staff
    TrialSite Staff February 27, 2021
    0 Comments
    SARS-CoV-2 Mutation and Vaccine Efficacy

    SARS-CoV-2 Mutation and Vaccine Efficacy

    In a January 25 piece in the New York Times, “As Virus Grows Stealthier, Vaccine Makers Reconsider Battle Plans,” they posit that the Moderna and…

    TrialSite Staff
    TrialSite Staff February 1, 2021
    0 Comments
    LA Times Writer Educates Readers About the Dangers of Mutant SARS-CoV-2 Variants TrialSite Suggests Far Better Global Coordination

    LA Times Writer Educates Readers About the Dangers of Mutant SARS-CoV-2 Variants: TrialSite Suggests Far Better Global Coordination

    TrialSite has reported that the two approved COVID-19 vaccines in the U.S. (Moderna and Pfizer/BioNTech) lose some of their effectiveness against the South African SARS-CoV-2…

    TrialSite Staff
    TrialSite Staff January 31, 2021
    2 Comments
    South African SARS-COV-2 Variant Makes It into South Carolina

    South African SARS-COV-2 Variant Makes It into South Carolina

    Three possibly more dangerous and transmissible coronavirus strains are spreading throughout the United States now from the United Kingdom (UK), Brazil and now South Africa.…

    TrialSite Staff
    TrialSite Staff January 28, 2021
    0 Comments
    Moderna COVID-19 Vaccine Retains Neutralizing Activity Against Variants but Six-Fold Reduction Against South Africa What About Brazil

    Moderna COVID-19 Vaccine Retains Neutralizing Activity Against Variants but Six-Fold Reduction Against South Africa: What About Brazil?

    Moderna announced the results from in vitro neutralization studies of sera from individuals vaccinated with Moderna COVID-19 Vaccine showing activity against emerging strains of SARS-CoV-2.…

    TrialSite Staff
    TrialSite Staff January 25, 2021
    0 Comments

    Read more about…

    Alzheimer Alzheimer's Disease Artificial Intelligence Autoimmune Disease Breast Cancer Cancer Cardiovascular Challenging Results China Clinical Research Clinical Research as a Care Option Clinical Trials CNS Coronavirus covid-19 COVID-19 Dementia Diabetes Digital Health Digital Media FDA Gene Therapy Immunotherapy India Investigator Content Investigator Profiles Investor Watch Ivermectin Leading Pharma Leading Sites Neurology NIH Oncology Patient Recruitment Pharma Watch Positive Results Price Watch Prostate Cancer Research SARS-CoV-2 Site Challenges Site Success Site Watch UK Vaccine

    About Us

    TRIALSITE NEWS IS  DEDICATED TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

    © 2021 - Trial Site News
    • Terms of Service
    • Privacy Policy

    TrialSite News
    159 W Broadway, Suite 200
    Salt Lake City, UT 84101

    Report Content

    Harassment or bullying behavior
    Contains mature or sensitive content
    Contains misleading or false information
    Contains abusive or derogatory content
    Anything overly promotional selling products or services

    Block Member?

    Please confirm you want to block this member.

    You will no longer be able to:

    • See blocked member's posts
    • Mention this member in posts
    • Invite this member to groups
    • Message this member
    • Add this member as a connection

    Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.